| Takeda, Affymax announce additional peginesatide Phase 3 study results in ... - News-Medical.net |
|
|
News-Medical.net These data, along with a demographic analysis from the dialysis studies, were part of three poster presentations at the National Kidney Foundation's (NKF) Spring Clinical Meetings in Las Vegas, Nevada. Peginesatide is in development for the treatment |